JAK1 and rheumatoid arthritis: JAKs (including JAK1, JAK2, JAK3, and TYK2) are ubiquitously expressed in various types of cells, including immune cells, synovial cells, osteoclasts, and osteoblasts, which together constitute the triangular immune-fibroblast-bone interaction underlying the bone damage in RA [19–21].